TOLLIP Protein Expression Predicts Unfavorable Outcome in Renal Cell Carcinoma

Resistance to systemic therapy is one of the hallmarks of renal cell carcinoma (RCC). Recently, TOLLIP has emerged as a possible driver of autophagy and chemoresistance. We explored the relationship between primary and metastatic RCC tumor characteristics, patient survival, and TOLLIP expression. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowalewski, Adam, Jaworski, Damian, Borowczak, Jędrzej, Maniewski, Mateusz, Szczerbowski, Krzysztof, Antosik, Paulina, Durślewicz, Justyna, Smolińska, Marta, Ligmanowska, Joanna, Grzanka, Dariusz, Szylberg, Łukasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741407/
https://www.ncbi.nlm.nih.gov/pubmed/36499030
http://dx.doi.org/10.3390/ijms232314702

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741407/
https://www.ncbi.nlm.nih.gov/pubmed/36499030
http://dx.doi.org/10.3390/ijms232314702

Ejemplares similares